Dashboard
Manage Tickers

XGN EXAGEN INC.

Nasdaq exagen.com


$ 9.54 $ -0.82 (-7.9 %)    

Friday, 07-Nov-2025 15:59:54 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 9.56
$ 10.20
$ 9.52 x 1,866
$ 10.82 x 41
$ 9.24 - $ 10.41
$ 2.62 - $ 12.23
683,808
na
216.66M
$ 0.80
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 07-29-2025 06-30-2025 10-Q
3 05-05-2025 03-31-2025 10-Q
4 03-11-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-05-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-18-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-20-2023 12-31-2022 10-K
13 11-21-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-22-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-11-2021 03-31-2021 10-Q
20 03-16-2021 12-31-2020 10-K
21 11-10-2020 09-30-2020 10-Q
22 07-28-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-25-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

b-riley-securities-reiterates-buy-on-exagen-raises-price-target-to-18
B. Riley Securities Reiterates Buy on Exag...
11/05/2025 17:26:21

B. Riley Securities analyst Anderson Schock reiterates Exagen (NASDAQ:XGN) with a Buy and raises the price target from $15 t...

correction-exagen-q3-adj-eps-019-misses-016-estimate-sales-17244m-beat-16895m-estimate
CORRECTION: Exagen Q3 Adj. EPS $(0.19) Mis...
11/04/2025 14:38:00

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.16) by 20...

exagen-affirms-fy2025-sales-guidance-of-65000m-70000m-vs-67487m-est
Exagen Affirms FY2025 Sales Guidance of $6...
11/04/2025 13:02:40

Exagen (NASDAQ:XGN) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 million vs $67...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

booking-holdings-to-rally-around-12-here-are-10-top-analyst-forecasts-for-monday
Booking Holdings To Rally Around 12%? Here...
10/27/2025 12:00:54

canaccord-genuity-maintains-buy-on-exagen-raises-price-target-to-15
Canaccord Genuity Maintains Buy on Exagen,...
10/27/2025 11:32:13

Canaccord Genuity analyst Kyle Mikson maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $11 to $15.

demystifying-exagen-insights-from-5-analyst-reviews
Demystifying Exagen: Insights From 5 Analy...
10/22/2025 14:00:46

btig-maintains-buy-on-exagen-raises-price-target-to-13
BTIG Maintains Buy on Exagen, Raises Price...
10/22/2025 12:05:45

BTIG analyst Mark Massaro maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $11 to $13.

keybanc-maintains-overweight-on-exagen-raises-price-target-to-15
Keybanc Maintains Overweight on Exagen, Ra...
10/14/2025 13:46:07

Keybanc analyst Paul Knight maintains Exagen (NASDAQ:XGN) with a Overweight and raises the price target from $12 to $15.

beyond-the-numbers-4-analysts-discuss-exagen-stock
Beyond The Numbers: 4 Analysts Discuss Exa...
09/11/2025 12:02:30

b-riley-securities-initiates-coverage-on-exagen-with-buy-rating-announces-price-target-of-15
B. Riley Securities Initiates Coverage On ...
09/11/2025 11:32:51

B. Riley Securities analyst Anderson Schock initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price ...

canaccord-genuity-maintains-buy-on-exagen-raises-price-target-to-11
Canaccord Genuity Maintains Buy on Exagen,...
07/30/2025 12:22:22

Canaccord Genuity analyst Kyle Mikson maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $8 to $11.

what-analysts-are-saying-about-exagen-stock
What Analysts Are Saying About Exagen Stock
07/30/2025 12:00:38

keybanc-upgrades-exagen-to-overweight-maintains-price-target-to-12
Keybanc Upgrades Exagen to Overweight, Mai...
07/30/2025 11:02:43

Keybanc analyst Paul Knight upgrades Exagen (NASDAQ:XGN) from Sector Weight to Overweight and maintains the price target fro...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 17:06:19

exagen-sees-fy2025-sales-65000m-70000m-vs-65515m-est
Exagen Sees FY2025 Sales $65.000M-$70.000M...
07/29/2025 13:10:44

Exagen (NASDAQ:XGN) sees FY2025 sales of $65.000 million-$70.000 million vs $65.515 million analyst estimate.

exagen-q2-adj-eps-018-misses-014-estimate-sales-17202m-beat-16233m-estimate
Exagen Q2 Adj. EPS $(0.18) Misses $(0.14) ...
07/29/2025 12:06:20

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.14) by 28...

Core News & Articles
Earnings Scheduled For July 29, 2025
07/29/2025 08:32:31

craig-hallum-initiates-coverage-on-exagen-with-buy-rating-announces-price-target-of-12
Craig-Hallum Initiates Coverage On Exagen ...
07/23/2025 18:14:01

Craig-Hallum analyst John Wilkin initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price Target of $12.

cantor-fitzgerald-maintains-overweight-on-exagen-lowers-price-target-to-7
Cantor Fitzgerald Maintains Overweight on ...
05/15/2025 15:36:22

Cantor Fitzgerald analyst Ross Osborn maintains Exagen (NASDAQ:XGN) with a Overweight and lowers the price target from $8 to...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION